atherosclerosis jon yap john a. burns school of medicine department of cell and molecular biology

17
ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

Upload: austin-sutton

Post on 17-Jan-2016

224 views

Category:

Documents


4 download

TRANSCRIPT

Page 1: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

ATHEROSCLEROSIS

Jon Yap

John A. Burns School of Medicine

Department of Cell and Molecular Biology

Page 2: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

Atherosclerosis by the Numbers• Cardiovascular diseases are the leading global cause of

death ~18 million deaths per year• Heart disease is the number one cause of death in the

United States >375,000 people/year• Heart disease strikes someone in the US ~every 43

seconds• Heart disease is the leading cause of death among

women, more than all forms of cancer combined• ~735,000 heart attacks/year in the US killing ~120,000

people

Page 3: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

Risk Factors• Preventable

• Type II diabetes/blood sugar• High fat, high cholesterol diet• Tobacco smoking• Sedentary lifestyle• High blood-preassure• Obesity

• Non-preventable• Advanced age• Heredity• Male

Page 4: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology
Page 5: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

Atherosclerosis

1. Circulating LDL infiltrate endothelial cell layer

2. LDL is modified (i.e. oxidation; ox-LDL)

3. Accumulation of ox-LDL elicits an immune response (recruitment of macrophages)

4. Activated macrophages release pro-inflammatory signaling molecules (cytokines)

5. Macrophages uptake ox-LDL via phagocytosis but are unable to digest the modified LDL

6. Lipid laden macrophages are characterized as foam cells

7. Foam cells accumulate forming the atherosclerotic plaque

Page 6: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

Lipoproteins• Lipoproteins are a biochemical complex of proteins and

bound lipids• Allow fats to move throughout the body• Low-density Lipoproteins

• Capable of entering arterial intima (sub-endothelial space)

• High-density Lipoproteins• Facilitate removal of cholesterol from the vasculature and to the

liver (digestion and absorption of dietary fats)

Page 7: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

LDL vs. HDL…

• High serum levels of free cholesterol result in elevated LDL in the vasculature

• LDL interacts with the ECM where it is retained

• LDL is modified (oxLDL) and taken up by macrophages

Page 8: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

LDL vs. HDL…

Reverse Cholesterol Transport: Free cholesterol is removed from the circulation by macrophages and is transferred back to the liver for digestion and biosynthesis of steroid hormones (i.e. androgens, estrogens, and glucocorticoids).

Page 9: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

Macrophages and Atherosclerosis

• Monocytes transmigrate through the endothelium in response to accumulating modified LDL and differentiate into macrophages

• Mature macrophages are activated by modified LDL and secrete inflammatory mediators

• Phagocytosis of modified LDL results in foam cell formation

Page 10: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

Foam Cells

Foam cells are unable to metabolize and efflux the cholesterol that they have accumulated. As a result, they die which exacerbates the inflammatory conditions in and around the atherosclerotic lesion.

Page 11: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

Atherosclerotic Plaque

Page 12: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

Necrotic core

Page 13: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

Thrombosis (Plaque Rupture)

Page 14: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

Vascular Occlusion

Hemodynamic pathologies associated with atherosclerotic plaque: Aside from plaque rupture, stable plaques can completely occlude vessels. The resulting lack of blood flow can have profound implications•Coronary artery disease leading to myocardio infarction•Ischemic stroke due to lack of adequate bloodflow to the brain

Page 15: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

Atherosclerotic Plaque

A. Plaque rupture without thrombusB. Acute coronary thrombosis with disruption of fiberous cap fatal

myocardial infarctionC. Massive plaque rupture with resulting thrombus fatal myocardial

infarction

Page 16: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

Summary • Atherosclerosis is an inflammatory disease, the

progression of which can be attributed to a prolonged immune response that ultimately compromises the structural integrity of the entire vascular system.

• Treaments• Statins (cholesterol lowering drugs)• Diet (decrease blood presure, cholesterol/fat intake)• Exercise (metabolic attenuation of caloric intake, loose weight)• Surgery (angioplasty, stent, bypass graft)

Page 17: ATHEROSCLEROSIS Jon Yap John A. Burns School of Medicine Department of Cell and Molecular Biology

Questions?